How T1D Exchange is Improving Care for People with Type 1 Diabetes
While you’re probably familiar with diabetes research related to getting new types of insulin or medications approved, you may not…
My A1c Dropped from 6.1 to 5.7% Using Inhaled Insulin: Ginger’s Story
This article is about Ginger’s experience using inhaled insulin and is intended to give a firsthand perspective on a product…
Improve Life with Diabetes by Participating in Research
Your voice matters. Often the biggest changes in anything are the result of something initially small. People with diabetes are…
4 Things to Consider When Choosing a Health Insurance Plan
Finding and choosing a health insurance plan for an individual or a family faced with the medical demands and costs…
Breaking Down the Science: How We Make Change Happen
Emily’s Story: Using Nasal Glucagon to Treat Severe Hypoglycemia
Emily Marcum was excited to take her parents, John and Andrea, on a 10-mile walking tour of Manhattan and Brooklyn…
Breaking Down the Science: The T1D Exchange Health Equity Advancement Lab Program
With so much data being gathered during the pandemic, COVID-19 research has revealed the glaring severity of healthcare inequities in…
Breaking Down the Science: The T1D and COVID-19 Surveillance Study
In March of 2020, T1D Exchange quickly recognized — along with the rest of the country — that COVID-19 was…
Vertex Pharmaceuticals Pursues Investigational Cell Therapies for Type 1 Diabetes
In the fall of 2019, Vertex Pharmaceuticals Incorporated acquired Semma Therapeutics for $950 million. Founded by Douglas Melton, Ph.D. and…
Breaking Down the Science: All About The T1D Exchange Quality Improvement Collaborative (QIC)
Providing supportive care for those living with T1D is complex and comes with an ongoing responsibility of knowing how to…
